Experimental obesity drug avoids brain effects that troubled predecessors (news – 2010) http://phys.org/news197905295.html
Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: A PET study (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24293119
Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23601084
Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: A PET study (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24293119
Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23601084